Facebook-f Instagram Twitter Linkedin Youtube
Frame 1

Breast Cancer

Cancer Nutrition in Cancer Care: A Brief, Practical Guide With a Focus on Clinical Practice

Leave a Comment / Breast Cancer /

Cancer Nutrition in Cancer Care: A Brief, Practical Guide With a Focus on Clinical Practice Question: Are cancer patients receiving appropriate nutritional screening, assessment, and interventions? SUMMARY ANSWER: Cancer Nutrition plays a crucial role for patients with cancer; however, nutritional problems are often under-prioritised, underdiagnosed, and undertreated, thereby affecting treatment outcomes and quality of life WHAT […]

Cancer Nutrition in Cancer Care: A Brief, Practical Guide With a Focus on Clinical Practice Read More »

Good Nutrition : The Fifth Pillar Of Cancer Treatment Good Nutrition

Leave a Comment / Breast Cancer, Nutrition /

Good Nutrition: The Fifth Pillar Of Cancer Treatment Cancer occurs due to the uncontrolled growth of cells, which are the basic building blocks of the body. Receiving a cancer diagnosis is often a distressing experience, followed by significant pain, suffering, and heartbreak. Despite substantial advances in cancer research and management over the past few decades,

Good Nutrition : The Fifth Pillar Of Cancer Treatment Good Nutrition Read More »

Real world Evidence with Palbociclib in HR+/HER2- MBC in Indian population

Leave a Comment / Breast Cancer /

Real world Evidence with Palbociclib in HR+/HER2- MBC in Indian population The combination of cyclin dependent kinase 4/6 inhibitors with endocrine therapy is the standard therapy in hormone receptor positive HER-2 negative metastatic breast cancer (HR+/HER2− MBC). Several randomized trials have shown the benefits of this combination, however, real world evidence in the Indian patients

Real world Evidence with Palbociclib in HR+/HER2- MBC in Indian population Read More »

CDK-4/6 inhibitors for the treatment of HR+/HER2 – advanced/metastatic breast cancer

Breast Cancer /

CDK-4/6 inhibitors for the treatment of HR+/HER2 – advanced/metastatic breast cancer CDK-4/6 inhibitors for the treatment of HR+/HER2 The combination of cyclin dependent kinase 4/6 inhibitors with endocrine therapy is the standard therapy in hormone receptor positive HER-2 negative metastatic breast cancer (HR+/HER2− MBC). Several randomized trials have shown the benefits of this combination. Hormone

CDK-4/6 inhibitors for the treatment of HR+/HER2 – advanced/metastatic breast cancer Read More »

Scroll to Top